Vascularization of rat pituitary autografts

Journal of Anatomy

Volumn 208, Issue 5, 2006, Pages 587-593

  Lombardero, Matilde ^a   Quintanar Stephano, Andres ^b   Vidal, Sergio ^a,c   Horvath, Eva ^c   Kovacs, Kalman ^c   Lloyd, Ricardo V ^d   Scheithauer, Bernd W ^d  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

Angiogenesis; Morphology; Pituitary; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN;

ADENOHYPOPHYSIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; CAPILLARY ENDOTHELIUM; CELL TYPE; CONTROLLED STUDY; FENESTRATION; HISTOPATHOLOGY; HYPOPHYSECTOMY; HYPOPHYSIS; HYPOTHALAMUS; HYPOXIA; IMMUNOHISTOCHEMISTRY; KIDNEY CAPSULE; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RAT STRAIN; TRANSMISSION ELECTRON MICROSCOPY; VASCULARIZATION;

ANIMALS; BIOLOGICAL MARKERS; HYPOPHYSECTOMY; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTOMY; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33646041891     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2006.00571.x     Document Type: Article

References (38)

1. Alvarez-Buylla R, Quintanar Stephano AQ, Quintanar Stephano JL, De Alvarez Buylla E (1991) Technical note: Removal of the unfragmented pituitary gland (hypophysectomy) in the rat. Bol Estud Med Biol 39, 33-38.
2. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL (2000) Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60, 7106-7113.
3. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146, 1029-1039.
4. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161, 851-858.
5. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18, 4-25.
6. Ferrara N, LeCouter J, Lin R (2002) Endocrine gland vascular endothelial growth factor (EG-VEGF) and the hypothesis of tissue-specific regulation of angiogenesis. Endocr Res 28, 763-764.
7. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U (1999) Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 160, 483-490.
8. Hammond PJ, Khandan-Nia N, Withers DJ, Jones PM, Ghatei MA, Bloom SR (1997) Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status. J Endocrinol 152, 211-219.
9. Jabbour HN, Boddy SC, Lincoln GA (1997) Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: Expression is independent of hypothalamic control. Mol Cell Endocrinol 134, 91-100.
10. Kovacs K (1961) Histological alterations in the rat pituitary transplanted to the eye. J Endocrinol 23, 109-117.
11. Kovacs K, Lloyd R, Horvath E, et al. (1989) Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocyhistochemistry, electron microscopy, in vitro examination and in situ hybridization. Am J Pathol 134, 345-353.
12. Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, et al. (1991) Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat Histopathol 418, 439-446.
13. Kuwai T, Kitadai Y, Tanaka S, et al. (2003) Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105, 176-181.
14. LeCouter J, Kowalski J, Foster J, et al. (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877-884.
15. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
16. Lloyd RV, Vidal S, Horvath E, Kovacs K, Scheithauer B (2003) Angiogenesis in normal and neoplastic pituitary tissues. Microsc Res Tech 60, 244-250.
17. McCabe CJ, Boelaert K, Tannahill LA, et al. (2002) Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87, 4238-4244.
18. Millauer B, Wizigmann-Voos S, Schnurch H, et al. (1993) High afinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
19. Moro M, Inada Y, Miyata H, Komatsu H, Kojima M, Tsujii H (2001) Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats. Clin Exp Pharmacol Physiol 28, 651-658.
20. Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, Messing EM (2003) Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. J Urol 170, 588-592.
21. Quintanar-Stephano AQ, Quintanar JL (1994) Hipofisectomia parafaringea en la rata (descripcion de la tecnica). Vet Mexico 1, 13-17.
22. Rak J, Mitsuhashi Y, Bayko L, et al. (1995) Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res 55, 4575-4580.
23. Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18, 206-228.
24. Renner U, Pagotto U, Arzt E, Stalla GK (1996) Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: A review. Eur J Endocrinol 135, 515-532.
25. Ribatti D, Nico B, Morbidelli L, et al. (2001) Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: Endothelial fenestration and angiogenesis. J Vasc Res 38, 389-397.
26. Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108, 2369-2379.
27. Sanno N, Teramoto A, Osamura R (2001) Tyramide amplification. In: Morphology Methods: Cell and Molecular Biology Techniques (ed. Lloyd RV), pp. 267-276. New Jersey: Humana Press.
28. Szentagothai J, Flerko B, Mess B, Halaz B (1968) The trophic dependence of the anterior pituitary on the diencephalons; the hypophysiotrophic area of the hypothalamus. In: Hypothalamic Control of the Anterior Pituitary. An Experimental-Morphological Study, pp. 111-156. Budapest: Akademiai Kiado.
29. Tiboldi T, Viragh S, Kovacs K, Hodi M, Julesz M (1967) Electronmicroscopic studies of oestrogen induced adenomata developing intrasellar and transplanted rat anterior pituitary. J Microsc (Paris) 6, 677-689.
30. Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24, 600-632.
31. Vidal S, Roman A, Oliveira MC, De la Cruz LF (1998) Simultaneous localization of Pit-1 protein and gonadotropins on the same cell type in the anterior pituitary glands of the rat. Histochem Cell Biol 110, 183-188.
32. Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW (1999) Vascular endothelial growth factor (VEGF) expression in nontumorous human pituitaries. Endocr Pathol 10, 109-122.
33. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438, 595-602.
34. Vidal S, Horvath E, Kovacs K, Kuroki T, Lloyd RV, Scheithauer BW (2003) Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours. Histol Histopathol 18, 679-686.
35. Yamada S, Takada K (2003) Angiogenesis in pituitary adenomas. Microsc Res Tech 60, 236-243.
36. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
37. Yasuda S, Arii S, Mori A, et al. (2004) Hexokinase II and VEGF expression in liver tumors: Correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol 40, 117-123.
38. Zhang X, Horwitz GA, Heaney AP, et al. (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84, 761-767